Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Automated Airways Characterization and Assessment of Cystic Fibrosis from CT Imaging.

medRxiv : the preprint server for health sciences·2026
Same author

WSB.APP/PS1 mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular dysfunction, and white matter deficits.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Neurovascular-metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Multiscale metabolic covariance networks uncover stage-specific biomarker signatures across the Alzheimer's disease continuum.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Multidomain Analysis of Clinical Cognitive Assessments and Imaging Data in Alzheimer's Disease Accurately Predicts Disease Stage and Grade Independent of Amyloid and Tau.

bioRxiv : the preprint server for biology·2026
Same author

Humanized Klotho haplotypes cause widespread transcriptomic changes in mouse brain.

bioRxiv : the preprint server for biology·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Juan Antonio Kim Hoo Chong Chie1, Scott A Persohn2, Ravi S Pandey3

  • 1Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

大脑中的代谢和血管功能障碍 (MVD) 模式显示出早期阿尔茨海默氏症诊断的前景. 这些综合成像措施提供了一个敏感的工具,用于检测有风险的区域,改善患者监测和治疗策略.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经成像是一种神经成像.
  • 阿尔茨海默氏症疾病研究研究
  • 生物标志物发现发现

背景情况:

  • 目前的阿尔茨海默氏症和相关痴呆症 (ADRD) 诊断依赖于晚期成像,错过了早期的损伤.
  • 在当前的诊断方法表现出敏感性之前,发生了不可逆转的脑损伤.
  • 区域代谢和血管功能障碍 (MVD) 可能在ADRD频谱中更早被检测出来.

研究的目的:

  • 测试MVD是ADRD的早期,敏感,非侵入性诊断工具的假设.
  • 在从认知正常 (CN) 到阿尔茨海默病 (AD) 的回顾性临床人群中调查MVD模式.

主要方法:

  • 使用了来自290名ADNI参与者的18F-FDG PET和ASL MRI数据 (CN,MCI,AD).
  • 生成脑血流 (CBF) 和PET图像,将其记录在地图上,并计算出相对于CN的区域z-score.
  • 使用t测试和等级分类对风险区域进行分析,与转录和认知数据保持一致.

主要成果:

  • 疾病的进展遵循一个明显的MVD模式,使得依赖于阶段的风险大脑区域的检测成为可能.
  • 患有MCI的患者表现出1型 (↓18F-FDG, ↑CBF) 和2型 (↑18F-FDG, ↓CBF) 的MVD.
  • 阿尔茨海默病患者表现出前体 (↑18F-FDG, ↑CBF) 和神经代谢血管衰竭 (↓18F-FDG, ↓CBF) 的MVD表型.
  • 观察到MVD模式,转录组签名和认知评估之间的对齐.

结论:

  • 风险大脑区域的MVD模式受性别,APOE状态,年龄和疾病阶段的影响.
  • MVD模式为早期ADRD检测提供了一种敏感的诊断方法.
  • 这种方法可以提高患者监测,分层和治疗方法的测试.